nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethosuximide—CACNA1G—epilepsy syndrome	0.156	1	CbGaD
Ethosuximide—CACNA1G—Trimethadione—epilepsy syndrome	0.0511	0.242	CbGbCtD
Ethosuximide—Decreased Central Nervous System Disorganized Electrical Activity—Trimethadione—epilepsy syndrome	0.0484	0.0875	CiPCiCtD
Ethosuximide—Decreased Central Nervous System Disorganized Electrical Activity—Felbamate—epilepsy syndrome	0.0484	0.0875	CiPCiCtD
Ethosuximide—Decreased Central Nervous System Disorganized Electrical Activity—Levetiracetam—epilepsy syndrome	0.0484	0.0875	CiPCiCtD
Ethosuximide—Decreased Central Nervous System Disorganized Electrical Activity—Lacosamide—epilepsy syndrome	0.0484	0.0875	CiPCiCtD
Ethosuximide—Decreased Central Nervous System Disorganized Electrical Activity—Fosphenytoin—epilepsy syndrome	0.0484	0.0875	CiPCiCtD
Ethosuximide—Decreased Central Nervous System Disorganized Electrical Activity—Oxcarbazepine—epilepsy syndrome	0.0484	0.0875	CiPCiCtD
Ethosuximide—Decreased Central Nervous System Disorganized Electrical Activity—Primidone—epilepsy syndrome	0.0484	0.0875	CiPCiCtD
Ethosuximide—Decreased Central Nervous System Disorganized Electrical Activity—Lamotrigine—epilepsy syndrome	0.0484	0.0875	CiPCiCtD
Ethosuximide—Decreased Central Nervous System Disorganized Electrical Activity—Valproic Acid—epilepsy syndrome	0.0367	0.0663	CiPCiCtD
Ethosuximide—Decreased Central Nervous System Disorganized Electrical Activity—Gabapentin—epilepsy syndrome	0.0367	0.0663	CiPCiCtD
Ethosuximide—Decreased Central Nervous System Disorganized Electrical Activity—Zonisamide—epilepsy syndrome	0.0278	0.0503	CiPCiCtD
Ethosuximide—CACNA1G—Zonisamide—epilepsy syndrome	0.0255	0.121	CbGbCtD
Ethosuximide—Decreased Central Nervous System Disorganized Electrical Activity—Carbamazepine—epilepsy syndrome	0.0236	0.0427	CiPCiCtD
Ethosuximide—Decreased Central Nervous System Disorganized Electrical Activity—Phenytoin—epilepsy syndrome	0.0211	0.0381	CiPCiCtD
Ethosuximide—Decreased Central Nervous System Disorganized Electrical Activity—Topiramate—epilepsy syndrome	0.0201	0.0363	CiPCiCtD
Ethosuximide—CYP2E1—Trimethadione—epilepsy syndrome	0.00719	0.034	CbGbCtD
Ethosuximide—CYP2E1—Felbamate—epilepsy syndrome	0.00719	0.034	CbGbCtD
Ethosuximide—CYP2E1—Clonazepam—epilepsy syndrome	0.00612	0.0289	CbGbCtD
Ethosuximide—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00601	0.0285	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.00503	0.0238	CbGbCtD
Ethosuximide—CYP3A7—Carbamazepine—epilepsy syndrome	0.00503	0.0238	CbGbCtD
Ethosuximide—CYP2E1—Rufinamide—epilepsy syndrome	0.00499	0.0236	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.00451	0.0214	CbGbCtD
Ethosuximide—CYP3A7—Phenytoin—epilepsy syndrome	0.00451	0.0214	CbGbCtD
Ethosuximide—CYP2E1—Propofol—epilepsy syndrome	0.00406	0.0192	CbGbCtD
Ethosuximide—CYP3A7—Phenobarbital—epilepsy syndrome	0.00402	0.019	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00402	0.019	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00397	0.0188	CbGbCtD
Ethosuximide—CYP3A7—Midazolam—epilepsy syndrome	0.00397	0.0188	CbGbCtD
Ethosuximide—CYP2E1—Phenobarbital—epilepsy syndrome	0.00388	0.0184	CbGbCtD
Ethosuximide—CYP2E1—Midazolam—epilepsy syndrome	0.00383	0.0181	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00381	0.0181	CbGbCtD
Ethosuximide—CYP3A7—Diazepam—epilepsy syndrome	0.00381	0.0181	CbGbCtD
Ethosuximide—CYP3A5—Carbamazepine—epilepsy syndrome	0.00378	0.0179	CbGbCtD
Ethosuximide—CYP2E1—Diazepam—epilepsy syndrome	0.00368	0.0174	CbGbCtD
Ethosuximide—CYP3A5—Phenytoin—epilepsy syndrome	0.00339	0.016	CbGbCtD
Ethosuximide—CYP3A5—Phenobarbital—epilepsy syndrome	0.00302	0.0143	CbGbCtD
Ethosuximide—CYP3A5—Midazolam—epilepsy syndrome	0.00298	0.0141	CbGbCtD
Ethosuximide—CYP3A5—Diazepam—epilepsy syndrome	0.00286	0.0135	CbGbCtD
Ethosuximide—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00234	0.0111	CbGbCtD
Ethosuximide—CYP3A5—Valproic Acid—epilepsy syndrome	0.00226	0.0107	CbGbCtD
Ethosuximide—CYP3A4—Felbamate—epilepsy syndrome	0.00218	0.0103	CbGbCtD
Ethosuximide—CYP3A4—Trimethadione—epilepsy syndrome	0.00218	0.0103	CbGbCtD
Ethosuximide—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00205	0.0097	CbGbCtD
Ethosuximide—CYP3A4—Clonazepam—epilepsy syndrome	0.00185	0.00877	CbGbCtD
Ethosuximide—CYP3A4—Clobazam—epilepsy syndrome	0.00178	0.00841	CbGbCtD
Ethosuximide—CYP3A4—Rufinamide—epilepsy syndrome	0.00151	0.00715	CbGbCtD
Ethosuximide—CYP3A4—Carbamazepine—epilepsy syndrome	0.00147	0.00697	CbGbCtD
Ethosuximide—CYP3A4—Primidone—epilepsy syndrome	0.00137	0.00651	CbGbCtD
Ethosuximide—CYP3A4—Phenytoin—epilepsy syndrome	0.00132	0.00625	CbGbCtD
Ethosuximide—CYP3A4—Propofol—epilepsy syndrome	0.00123	0.00583	CbGbCtD
Ethosuximide—CYP3A4—Acetazolamide—epilepsy syndrome	0.00118	0.00557	CbGbCtD
Ethosuximide—CYP3A4—Phenobarbital—epilepsy syndrome	0.00118	0.00557	CbGbCtD
Ethosuximide—CYP3A4—Midazolam—epilepsy syndrome	0.00116	0.00549	CbGbCtD
Ethosuximide—CYP3A4—Diazepam—epilepsy syndrome	0.00112	0.00528	CbGbCtD
Ethosuximide—CYP3A4—Zonisamide—epilepsy syndrome	0.00109	0.00515	CbGbCtD
Ethosuximide—CYP3A4—Valproic Acid—epilepsy syndrome	0.00088	0.00416	CbGbCtD
Ethosuximide—CYP3A4—Topiramate—epilepsy syndrome	0.000794	0.00376	CbGbCtD
Ethosuximide—Methyprylon—GABRG2—epilepsy syndrome	0.000713	0.365	CrCbGaD
Ethosuximide—Methyprylon—GABRB3—epilepsy syndrome	0.000574	0.294	CrCbGaD
Ethosuximide—Methyprylon—GABRA1—epilepsy syndrome	0.000493	0.252	CrCbGaD
Ethosuximide—Methyprylon—CYP2D6—epilepsy syndrome	0.000172	0.088	CrCbGaD
Ethosuximide—Abdominal pain—Felbamate—epilepsy syndrome	3.22e-05	0.000522	CcSEcCtD
Ethosuximide—Vomiting—Acetazolamide—epilepsy syndrome	3.22e-05	0.000522	CcSEcCtD
Ethosuximide—Diarrhoea—Propofol—epilepsy syndrome	3.22e-05	0.000522	CcSEcCtD
Ethosuximide—Immune system disorder—Pregabalin—epilepsy syndrome	3.22e-05	0.000521	CcSEcCtD
Ethosuximide—Mediastinal disorder—Pregabalin—epilepsy syndrome	3.21e-05	0.00052	CcSEcCtD
Ethosuximide—Connective tissue disorder—Gabapentin—epilepsy syndrome	3.21e-05	0.00052	CcSEcCtD
Ethosuximide—Urethral disorder—Gabapentin—epilepsy syndrome	3.2e-05	0.000519	CcSEcCtD
Ethosuximide—Headache—Acetazolamide—epilepsy syndrome	3.18e-05	0.000514	CcSEcCtD
Ethosuximide—Urticaria—Zonisamide—epilepsy syndrome	3.17e-05	0.000514	CcSEcCtD
Ethosuximide—Decreased appetite—Carbamazepine—epilepsy syndrome	3.17e-05	0.000513	CcSEcCtD
Ethosuximide—Abdominal pain—Zonisamide—epilepsy syndrome	3.16e-05	0.000511	CcSEcCtD
Ethosuximide—Agitation—Valproic Acid—epilepsy syndrome	3.15e-05	0.000511	CcSEcCtD
Ethosuximide—Hypersensitivity—Vigabatrin—epilepsy syndrome	3.15e-05	0.000511	CcSEcCtD
Ethosuximide—Asthenia—Fosphenytoin—epilepsy syndrome	3.15e-05	0.00051	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	3.15e-05	0.00051	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Clonazepam—epilepsy syndrome	3.15e-05	0.000509	CcSEcCtD
Ethosuximide—Fatigue—Carbamazepine—epilepsy syndrome	3.14e-05	0.000509	CcSEcCtD
Ethosuximide—Somnolence—Lamotrigine—epilepsy syndrome	3.13e-05	0.000508	CcSEcCtD
Ethosuximide—Mental disorder—Pregabalin—epilepsy syndrome	3.12e-05	0.000506	CcSEcCtD
Ethosuximide—Dizziness—Propofol—epilepsy syndrome	3.11e-05	0.000504	CcSEcCtD
Ethosuximide—Diarrhoea—Levetiracetam—epilepsy syndrome	3.11e-05	0.000504	CcSEcCtD
Ethosuximide—Weight decreased—Topiramate—epilepsy syndrome	3.11e-05	0.000503	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	3.11e-05	0.000503	CcSEcCtD
Ethosuximide—Hypersensitivity—Diazepam—epilepsy syndrome	3.1e-05	0.000503	CcSEcCtD
Ethosuximide—Malnutrition—Pregabalin—epilepsy syndrome	3.1e-05	0.000503	CcSEcCtD
Ethosuximide—Erythema multiforme—Gabapentin—epilepsy syndrome	3.09e-05	0.0005	CcSEcCtD
Ethosuximide—Leukopenia—Valproic Acid—epilepsy syndrome	3.07e-05	0.000498	CcSEcCtD
Ethosuximide—Asthenia—Vigabatrin—epilepsy syndrome	3.07e-05	0.000497	CcSEcCtD
Ethosuximide—Decreased appetite—Lamotrigine—epilepsy syndrome	3.06e-05	0.000496	CcSEcCtD
Ethosuximide—Urticaria—Clonazepam—epilepsy syndrome	3.06e-05	0.000495	CcSEcCtD
Ethosuximide—Eye disorder—Gabapentin—epilepsy syndrome	3.05e-05	0.000495	CcSEcCtD
Ethosuximide—Dizziness—Midazolam—epilepsy syndrome	3.05e-05	0.000493	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	3.04e-05	0.000493	CcSEcCtD
Ethosuximide—Abdominal pain—Clonazepam—epilepsy syndrome	3.04e-05	0.000492	CcSEcCtD
Ethosuximide—Fatigue—Lamotrigine—epilepsy syndrome	3.04e-05	0.000492	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Topiramate—epilepsy syndrome	3.04e-05	0.000492	CcSEcCtD
Ethosuximide—Urticaria—Phenytoin—epilepsy syndrome	3.04e-05	0.000492	CcSEcCtD
Ethosuximide—Asthenia—Diazepam—epilepsy syndrome	3.02e-05	0.00049	CcSEcCtD
Ethosuximide—Urticaria—Oxcarbazepine—epilepsy syndrome	3.02e-05	0.000489	CcSEcCtD
Ethosuximide—Nausea—Acetazolamide—epilepsy syndrome	3.01e-05	0.000488	CcSEcCtD
Ethosuximide—Dizziness—Levetiracetam—epilepsy syndrome	3.01e-05	0.000487	CcSEcCtD
Ethosuximide—Abdominal pain—Oxcarbazepine—epilepsy syndrome	3e-05	0.000487	CcSEcCtD
Ethosuximide—Diarrhoea—Fosphenytoin—epilepsy syndrome	3e-05	0.000486	CcSEcCtD
Ethosuximide—Vomiting—Propofol—epilepsy syndrome	2.99e-05	0.000485	CcSEcCtD
Ethosuximide—Muscle spasms—Pregabalin—epilepsy syndrome	2.98e-05	0.000483	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	2.98e-05	0.000483	CcSEcCtD
Ethosuximide—Rash—Propofol—epilepsy syndrome	2.97e-05	0.000481	CcSEcCtD
Ethosuximide—Dermatitis—Propofol—epilepsy syndrome	2.97e-05	0.00048	CcSEcCtD
Ethosuximide—Immune system disorder—Gabapentin—epilepsy syndrome	2.95e-05	0.000478	CcSEcCtD
Ethosuximide—Headache—Propofol—epilepsy syndrome	2.95e-05	0.000478	CcSEcCtD
Ethosuximide—Mediastinal disorder—Gabapentin—epilepsy syndrome	2.95e-05	0.000477	CcSEcCtD
Ethosuximide—Hypersensitivity—Zonisamide—epilepsy syndrome	2.94e-05	0.000476	CcSEcCtD
Ethosuximide—Vomiting—Midazolam—epilepsy syndrome	2.93e-05	0.000474	CcSEcCtD
Ethosuximide—Diarrhoea—Vigabatrin—epilepsy syndrome	2.93e-05	0.000474	CcSEcCtD
Ethosuximide—Asthenia—Felbamate—epilepsy syndrome	2.93e-05	0.000474	CcSEcCtD
Ethosuximide—Haematuria—Topiramate—epilepsy syndrome	2.92e-05	0.000473	CcSEcCtD
Ethosuximide—Rash—Midazolam—epilepsy syndrome	2.9e-05	0.00047	CcSEcCtD
Ethosuximide—Dizziness—Fosphenytoin—epilepsy syndrome	2.9e-05	0.00047	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	2.9e-05	0.00047	CcSEcCtD
Ethosuximide—Dermatitis—Midazolam—epilepsy syndrome	2.9e-05	0.00047	CcSEcCtD
Ethosuximide—Urticaria—Carbamazepine—epilepsy syndrome	2.9e-05	0.000469	CcSEcCtD
Ethosuximide—Vomiting—Levetiracetam—epilepsy syndrome	2.89e-05	0.000468	CcSEcCtD
Ethosuximide—Headache—Midazolam—epilepsy syndrome	2.89e-05	0.000467	CcSEcCtD
Ethosuximide—Abdominal pain—Carbamazepine—epilepsy syndrome	2.88e-05	0.000467	CcSEcCtD
Ethosuximide—Diarrhoea—Diazepam—epilepsy syndrome	2.88e-05	0.000467	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	2.88e-05	0.000467	CcSEcCtD
Ethosuximide—Rash—Levetiracetam—epilepsy syndrome	2.87e-05	0.000465	CcSEcCtD
Ethosuximide—Dermatitis—Levetiracetam—epilepsy syndrome	2.87e-05	0.000464	CcSEcCtD
Ethosuximide—Asthenia—Zonisamide—epilepsy syndrome	2.86e-05	0.000464	CcSEcCtD
Ethosuximide—Mental disorder—Gabapentin—epilepsy syndrome	2.86e-05	0.000464	CcSEcCtD
Ethosuximide—Agranulocytosis—Topiramate—epilepsy syndrome	2.86e-05	0.000463	CcSEcCtD
Ethosuximide—Agitation—Pregabalin—epilepsy syndrome	2.85e-05	0.000462	CcSEcCtD
Ethosuximide—Headache—Levetiracetam—epilepsy syndrome	2.85e-05	0.000462	CcSEcCtD
Ethosuximide—Malnutrition—Gabapentin—epilepsy syndrome	2.85e-05	0.000461	CcSEcCtD
Ethosuximide—Hypersensitivity—Clonazepam—epilepsy syndrome	2.83e-05	0.000459	CcSEcCtD
Ethosuximide—Dizziness—Vigabatrin—epilepsy syndrome	2.83e-05	0.000458	CcSEcCtD
Ethosuximide—Hypersensitivity—Phenytoin—epilepsy syndrome	2.82e-05	0.000456	CcSEcCtD
Ethosuximide—Urticaria—Lamotrigine—epilepsy syndrome	2.8e-05	0.000454	CcSEcCtD
Ethosuximide—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	2.8e-05	0.000454	CcSEcCtD
Ethosuximide—Nausea—Propofol—epilepsy syndrome	2.8e-05	0.000453	CcSEcCtD
Ethosuximide—Vomiting—Fosphenytoin—epilepsy syndrome	2.79e-05	0.000452	CcSEcCtD
Ethosuximide—Diarrhoea—Felbamate—epilepsy syndrome	2.79e-05	0.000452	CcSEcCtD
Ethosuximide—Abdominal pain—Lamotrigine—epilepsy syndrome	2.79e-05	0.000451	CcSEcCtD
Ethosuximide—Dizziness—Diazepam—epilepsy syndrome	2.79e-05	0.000451	CcSEcCtD
Ethosuximide—Leukopenia—Pregabalin—epilepsy syndrome	2.78e-05	0.00045	CcSEcCtD
Ethosuximide—Rash—Fosphenytoin—epilepsy syndrome	2.77e-05	0.000448	CcSEcCtD
Ethosuximide—Dermatitis—Fosphenytoin—epilepsy syndrome	2.77e-05	0.000448	CcSEcCtD
Ethosuximide—Asthenia—Clonazepam—epilepsy syndrome	2.76e-05	0.000447	CcSEcCtD
Ethosuximide—Headache—Fosphenytoin—epilepsy syndrome	2.75e-05	0.000445	CcSEcCtD
Ethosuximide—Nervous system disorder—Valproic Acid—epilepsy syndrome	2.75e-05	0.000445	CcSEcCtD
Ethosuximide—Asthenia—Phenytoin—epilepsy syndrome	2.74e-05	0.000444	CcSEcCtD
Ethosuximide—Nausea—Midazolam—epilepsy syndrome	2.74e-05	0.000443	CcSEcCtD
Ethosuximide—Muscle spasms—Gabapentin—epilepsy syndrome	2.74e-05	0.000443	CcSEcCtD
Ethosuximide—Diarrhoea—Zonisamide—epilepsy syndrome	2.73e-05	0.000442	CcSEcCtD
Ethosuximide—Asthenia—Oxcarbazepine—epilepsy syndrome	2.73e-05	0.000442	CcSEcCtD
Ethosuximide—Vomiting—Vigabatrin—epilepsy syndrome	2.72e-05	0.000441	CcSEcCtD
Ethosuximide—Skin disorder—Valproic Acid—epilepsy syndrome	2.72e-05	0.000441	CcSEcCtD
Ethosuximide—Urinary tract disorder—Topiramate—epilepsy syndrome	2.72e-05	0.00044	CcSEcCtD
Ethosuximide—Connective tissue disorder—Topiramate—epilepsy syndrome	2.7e-05	0.000438	CcSEcCtD
Ethosuximide—Nausea—Levetiracetam—epilepsy syndrome	2.7e-05	0.000438	CcSEcCtD
Ethosuximide—Rash—Vigabatrin—epilepsy syndrome	2.7e-05	0.000437	CcSEcCtD
Ethosuximide—Dizziness—Felbamate—epilepsy syndrome	2.7e-05	0.000437	CcSEcCtD
Ethosuximide—Dermatitis—Vigabatrin—epilepsy syndrome	2.7e-05	0.000437	CcSEcCtD
Ethosuximide—Urethral disorder—Topiramate—epilepsy syndrome	2.7e-05	0.000437	CcSEcCtD
Ethosuximide—Hypersensitivity—Carbamazepine—epilepsy syndrome	2.69e-05	0.000435	CcSEcCtD
Ethosuximide—Headache—Vigabatrin—epilepsy syndrome	2.68e-05	0.000434	CcSEcCtD
Ethosuximide—Vomiting—Diazepam—epilepsy syndrome	2.68e-05	0.000434	CcSEcCtD
Ethosuximide—Anorexia—Valproic Acid—epilepsy syndrome	2.67e-05	0.000432	CcSEcCtD
Ethosuximide—Rash—Diazepam—epilepsy syndrome	2.66e-05	0.00043	CcSEcCtD
Ethosuximide—Dermatitis—Diazepam—epilepsy syndrome	2.65e-05	0.00043	CcSEcCtD
Ethosuximide—Dizziness—Zonisamide—epilepsy syndrome	2.64e-05	0.000427	CcSEcCtD
Ethosuximide—Headache—Diazepam—epilepsy syndrome	2.64e-05	0.000427	CcSEcCtD
Ethosuximide—Diarrhoea—Clonazepam—epilepsy syndrome	2.63e-05	0.000426	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.62e-05	0.000425	CcSEcCtD
Ethosuximide—Asthenia—Carbamazepine—epilepsy syndrome	2.62e-05	0.000424	CcSEcCtD
Ethosuximide—Agitation—Gabapentin—epilepsy syndrome	2.61e-05	0.000423	CcSEcCtD
Ethosuximide—Diarrhoea—Phenytoin—epilepsy syndrome	2.61e-05	0.000423	CcSEcCtD
Ethosuximide—Nausea—Fosphenytoin—epilepsy syndrome	2.61e-05	0.000422	CcSEcCtD
Ethosuximide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.6e-05	0.000421	CcSEcCtD
Ethosuximide—Erythema multiforme—Topiramate—epilepsy syndrome	2.6e-05	0.000421	CcSEcCtD
Ethosuximide—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.6e-05	0.000421	CcSEcCtD
Ethosuximide—Vomiting—Felbamate—epilepsy syndrome	2.59e-05	0.00042	CcSEcCtD
Ethosuximide—Rash—Felbamate—epilepsy syndrome	2.57e-05	0.000416	CcSEcCtD
Ethosuximide—Eye disorder—Topiramate—epilepsy syndrome	2.57e-05	0.000416	CcSEcCtD
Ethosuximide—Dermatitis—Felbamate—epilepsy syndrome	2.57e-05	0.000416	CcSEcCtD
Ethosuximide—Headache—Felbamate—epilepsy syndrome	2.55e-05	0.000414	CcSEcCtD
Ethosuximide—Leukopenia—Gabapentin—epilepsy syndrome	2.55e-05	0.000412	CcSEcCtD
Ethosuximide—Dizziness—Clonazepam—epilepsy syndrome	2.54e-05	0.000412	CcSEcCtD
Ethosuximide—Nausea—Vigabatrin—epilepsy syndrome	2.54e-05	0.000412	CcSEcCtD
Ethosuximide—Vomiting—Zonisamide—epilepsy syndrome	2.54e-05	0.000411	CcSEcCtD
Ethosuximide—Asthenia—Lamotrigine—epilepsy syndrome	2.53e-05	0.00041	CcSEcCtD
Ethosuximide—Dizziness—Phenytoin—epilepsy syndrome	2.53e-05	0.000409	CcSEcCtD
Ethosuximide—Rash—Zonisamide—epilepsy syndrome	2.52e-05	0.000408	CcSEcCtD
Ethosuximide—Dermatitis—Zonisamide—epilepsy syndrome	2.51e-05	0.000407	CcSEcCtD
Ethosuximide—Dizziness—Oxcarbazepine—epilepsy syndrome	2.51e-05	0.000407	CcSEcCtD
Ethosuximide—Nausea—Diazepam—epilepsy syndrome	2.5e-05	0.000405	CcSEcCtD
Ethosuximide—Headache—Zonisamide—epilepsy syndrome	2.5e-05	0.000405	CcSEcCtD
Ethosuximide—Diarrhoea—Carbamazepine—epilepsy syndrome	2.5e-05	0.000404	CcSEcCtD
Ethosuximide—Somnolence—Valproic Acid—epilepsy syndrome	2.49e-05	0.000403	CcSEcCtD
Ethosuximide—Immune system disorder—Topiramate—epilepsy syndrome	2.48e-05	0.000402	CcSEcCtD
Ethosuximide—Nervous system disorder—Pregabalin—epilepsy syndrome	2.48e-05	0.000402	CcSEcCtD
Ethosuximide—Mediastinal disorder—Topiramate—epilepsy syndrome	2.48e-05	0.000401	CcSEcCtD
Ethosuximide—Skin disorder—Pregabalin—epilepsy syndrome	2.46e-05	0.000398	CcSEcCtD
Ethosuximide—Vomiting—Clonazepam—epilepsy syndrome	2.45e-05	0.000396	CcSEcCtD
Ethosuximide—Decreased appetite—Valproic Acid—epilepsy syndrome	2.43e-05	0.000394	CcSEcCtD
Ethosuximide—Vomiting—Phenytoin—epilepsy syndrome	2.43e-05	0.000393	CcSEcCtD
Ethosuximide—Rash—Clonazepam—epilepsy syndrome	2.43e-05	0.000393	CcSEcCtD
Ethosuximide—Dermatitis—Clonazepam—epilepsy syndrome	2.42e-05	0.000392	CcSEcCtD
Ethosuximide—Nausea—Felbamate—epilepsy syndrome	2.42e-05	0.000392	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.42e-05	0.000392	CcSEcCtD
Ethosuximide—Vomiting—Oxcarbazepine—epilepsy syndrome	2.42e-05	0.000391	CcSEcCtD
Ethosuximide—Fatigue—Valproic Acid—epilepsy syndrome	2.41e-05	0.000391	CcSEcCtD
Ethosuximide—Anorexia—Pregabalin—epilepsy syndrome	2.41e-05	0.000391	CcSEcCtD
Ethosuximide—Dizziness—Carbamazepine—epilepsy syndrome	2.41e-05	0.000391	CcSEcCtD
Ethosuximide—Diarrhoea—Lamotrigine—epilepsy syndrome	2.41e-05	0.000391	CcSEcCtD
Ethosuximide—Headache—Clonazepam—epilepsy syndrome	2.41e-05	0.00039	CcSEcCtD
Ethosuximide—Rash—Phenytoin—epilepsy syndrome	2.41e-05	0.00039	CcSEcCtD
Ethosuximide—Mental disorder—Topiramate—epilepsy syndrome	2.41e-05	0.00039	CcSEcCtD
Ethosuximide—Dermatitis—Phenytoin—epilepsy syndrome	2.41e-05	0.00039	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.41e-05	0.00039	CcSEcCtD
Ethosuximide—Rash—Oxcarbazepine—epilepsy syndrome	2.4e-05	0.000388	CcSEcCtD
Ethosuximide—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.39e-05	0.000388	CcSEcCtD
Ethosuximide—Headache—Phenytoin—epilepsy syndrome	2.39e-05	0.000388	CcSEcCtD
Ethosuximide—Malnutrition—Topiramate—epilepsy syndrome	2.39e-05	0.000388	CcSEcCtD
Ethosuximide—Headache—Oxcarbazepine—epilepsy syndrome	2.38e-05	0.000386	CcSEcCtD
Ethosuximide—Nausea—Zonisamide—epilepsy syndrome	2.37e-05	0.000384	CcSEcCtD
Ethosuximide—Dizziness—Lamotrigine—epilepsy syndrome	2.33e-05	0.000378	CcSEcCtD
Ethosuximide—Vomiting—Carbamazepine—epilepsy syndrome	2.32e-05	0.000376	CcSEcCtD
Ethosuximide—Muscle spasms—Topiramate—epilepsy syndrome	2.3e-05	0.000373	CcSEcCtD
Ethosuximide—Rash—Carbamazepine—epilepsy syndrome	2.3e-05	0.000372	CcSEcCtD
Ethosuximide—Dermatitis—Carbamazepine—epilepsy syndrome	2.3e-05	0.000372	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.29e-05	0.000371	CcSEcCtD
Ethosuximide—Nausea—Clonazepam—epilepsy syndrome	2.28e-05	0.00037	CcSEcCtD
Ethosuximide—Headache—Carbamazepine—epilepsy syndrome	2.28e-05	0.00037	CcSEcCtD
Ethosuximide—Nervous system disorder—Gabapentin—epilepsy syndrome	2.28e-05	0.000369	CcSEcCtD
Ethosuximide—Nausea—Phenytoin—epilepsy syndrome	2.27e-05	0.000368	CcSEcCtD
Ethosuximide—Nausea—Oxcarbazepine—epilepsy syndrome	2.26e-05	0.000366	CcSEcCtD
Ethosuximide—Skin disorder—Gabapentin—epilepsy syndrome	2.26e-05	0.000365	CcSEcCtD
Ethosuximide—Somnolence—Pregabalin—epilepsy syndrome	2.25e-05	0.000365	CcSEcCtD
Ethosuximide—Vomiting—Lamotrigine—epilepsy syndrome	2.24e-05	0.000363	CcSEcCtD
Ethosuximide—Urticaria—Valproic Acid—epilepsy syndrome	2.23e-05	0.00036	CcSEcCtD
Ethosuximide—Rash—Lamotrigine—epilepsy syndrome	2.22e-05	0.00036	CcSEcCtD
Ethosuximide—Dermatitis—Lamotrigine—epilepsy syndrome	2.22e-05	0.00036	CcSEcCtD
Ethosuximide—Abdominal pain—Valproic Acid—epilepsy syndrome	2.21e-05	0.000359	CcSEcCtD
Ethosuximide—Anorexia—Gabapentin—epilepsy syndrome	2.21e-05	0.000358	CcSEcCtD
Ethosuximide—Headache—Lamotrigine—epilepsy syndrome	2.21e-05	0.000358	CcSEcCtD
Ethosuximide—Decreased appetite—Pregabalin—epilepsy syndrome	2.2e-05	0.000357	CcSEcCtD
Ethosuximide—Agitation—Topiramate—epilepsy syndrome	2.2e-05	0.000356	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.19e-05	0.000354	CcSEcCtD
Ethosuximide—Fatigue—Pregabalin—epilepsy syndrome	2.18e-05	0.000354	CcSEcCtD
Ethosuximide—Nausea—Carbamazepine—epilepsy syndrome	2.17e-05	0.000351	CcSEcCtD
Ethosuximide—Leukopenia—Topiramate—epilepsy syndrome	2.14e-05	0.000347	CcSEcCtD
Ethosuximide—Nausea—Lamotrigine—epilepsy syndrome	2.09e-05	0.000339	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.07e-05	0.000335	CcSEcCtD
Ethosuximide—Somnolence—Gabapentin—epilepsy syndrome	2.06e-05	0.000334	CcSEcCtD
Ethosuximide—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.06e-05	0.000334	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.02e-05	0.000328	CcSEcCtD
Ethosuximide—Decreased appetite—Gabapentin—epilepsy syndrome	2.02e-05	0.000327	CcSEcCtD
Ethosuximide—Urticaria—Pregabalin—epilepsy syndrome	2.01e-05	0.000326	CcSEcCtD
Ethosuximide—Asthenia—Valproic Acid—epilepsy syndrome	2.01e-05	0.000325	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2e-05	0.000325	CcSEcCtD
Ethosuximide—Fatigue—Gabapentin—epilepsy syndrome	2e-05	0.000324	CcSEcCtD
Ethosuximide—Abdominal pain—Pregabalin—epilepsy syndrome	2e-05	0.000324	CcSEcCtD
Ethosuximide—Diarrhoea—Valproic Acid—epilepsy syndrome	1.92e-05	0.00031	CcSEcCtD
Ethosuximide—Nervous system disorder—Topiramate—epilepsy syndrome	1.92e-05	0.00031	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.9e-05	0.000308	CcSEcCtD
Ethosuximide—Skin disorder—Topiramate—epilepsy syndrome	1.9e-05	0.000307	CcSEcCtD
Ethosuximide—Hypersensitivity—Pregabalin—epilepsy syndrome	1.87e-05	0.000302	CcSEcCtD
Ethosuximide—Anorexia—Topiramate—epilepsy syndrome	1.86e-05	0.000302	CcSEcCtD
Ethosuximide—Dizziness—Valproic Acid—epilepsy syndrome	1.85e-05	0.0003	CcSEcCtD
Ethosuximide—Urticaria—Gabapentin—epilepsy syndrome	1.84e-05	0.000299	CcSEcCtD
Ethosuximide—Abdominal pain—Gabapentin—epilepsy syndrome	1.84e-05	0.000297	CcSEcCtD
Ethosuximide—Asthenia—Pregabalin—epilepsy syndrome	1.82e-05	0.000294	CcSEcCtD
Ethosuximide—Vomiting—Valproic Acid—epilepsy syndrome	1.78e-05	0.000288	CcSEcCtD
Ethosuximide—Rash—Valproic Acid—epilepsy syndrome	1.77e-05	0.000286	CcSEcCtD
Ethosuximide—Dermatitis—Valproic Acid—epilepsy syndrome	1.76e-05	0.000286	CcSEcCtD
Ethosuximide—Headache—Valproic Acid—epilepsy syndrome	1.75e-05	0.000284	CcSEcCtD
Ethosuximide—Somnolence—Topiramate—epilepsy syndrome	1.74e-05	0.000281	CcSEcCtD
Ethosuximide—Diarrhoea—Pregabalin—epilepsy syndrome	1.73e-05	0.000281	CcSEcCtD
Ethosuximide—Hypersensitivity—Gabapentin—epilepsy syndrome	1.71e-05	0.000277	CcSEcCtD
Ethosuximide—Decreased appetite—Topiramate—epilepsy syndrome	1.7e-05	0.000275	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.69e-05	0.000273	CcSEcCtD
Ethosuximide—Fatigue—Topiramate—epilepsy syndrome	1.68e-05	0.000273	CcSEcCtD
Ethosuximide—Dizziness—Pregabalin—epilepsy syndrome	1.67e-05	0.000271	CcSEcCtD
Ethosuximide—Asthenia—Gabapentin—epilepsy syndrome	1.67e-05	0.00027	CcSEcCtD
Ethosuximide—Nausea—Valproic Acid—epilepsy syndrome	1.66e-05	0.000269	CcSEcCtD
Ethosuximide—Vomiting—Pregabalin—epilepsy syndrome	1.61e-05	0.000261	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.6e-05	0.000259	CcSEcCtD
Ethosuximide—Rash—Pregabalin—epilepsy syndrome	1.6e-05	0.000259	CcSEcCtD
Ethosuximide—Dermatitis—Pregabalin—epilepsy syndrome	1.6e-05	0.000258	CcSEcCtD
Ethosuximide—Diarrhoea—Gabapentin—epilepsy syndrome	1.59e-05	0.000257	CcSEcCtD
Ethosuximide—Headache—Pregabalin—epilepsy syndrome	1.59e-05	0.000257	CcSEcCtD
Ethosuximide—Urticaria—Topiramate—epilepsy syndrome	1.55e-05	0.000251	CcSEcCtD
Ethosuximide—Abdominal pain—Topiramate—epilepsy syndrome	1.54e-05	0.00025	CcSEcCtD
Ethosuximide—Dizziness—Gabapentin—epilepsy syndrome	1.54e-05	0.000249	CcSEcCtD
Ethosuximide—Nausea—Pregabalin—epilepsy syndrome	1.5e-05	0.000244	CcSEcCtD
Ethosuximide—Vomiting—Gabapentin—epilepsy syndrome	1.48e-05	0.000239	CcSEcCtD
Ethosuximide—Rash—Gabapentin—epilepsy syndrome	1.46e-05	0.000237	CcSEcCtD
Ethosuximide—Dermatitis—Gabapentin—epilepsy syndrome	1.46e-05	0.000237	CcSEcCtD
Ethosuximide—Headache—Gabapentin—epilepsy syndrome	1.45e-05	0.000236	CcSEcCtD
Ethosuximide—Hypersensitivity—Topiramate—epilepsy syndrome	1.44e-05	0.000233	CcSEcCtD
Ethosuximide—Asthenia—Topiramate—epilepsy syndrome	1.4e-05	0.000227	CcSEcCtD
Ethosuximide—Nausea—Gabapentin—epilepsy syndrome	1.38e-05	0.000223	CcSEcCtD
Ethosuximide—Diarrhoea—Topiramate—epilepsy syndrome	1.34e-05	0.000216	CcSEcCtD
Ethosuximide—Dizziness—Topiramate—epilepsy syndrome	1.29e-05	0.000209	CcSEcCtD
Ethosuximide—Vomiting—Topiramate—epilepsy syndrome	1.24e-05	0.000201	CcSEcCtD
Ethosuximide—Rash—Topiramate—epilepsy syndrome	1.23e-05	0.000199	CcSEcCtD
Ethosuximide—Dermatitis—Topiramate—epilepsy syndrome	1.23e-05	0.000199	CcSEcCtD
Ethosuximide—Headache—Topiramate—epilepsy syndrome	1.22e-05	0.000198	CcSEcCtD
Ethosuximide—Nausea—Topiramate—epilepsy syndrome	1.16e-05	0.000188	CcSEcCtD
Ethosuximide—CYP3A43—Metabolism—CYP11A1—epilepsy syndrome	8.87e-06	0.000548	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—COX3—epilepsy syndrome	8.72e-06	0.000539	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—SLC6A8—epilepsy syndrome	8.26e-06	0.000511	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CACNA2D2—epilepsy syndrome	8.26e-06	0.000511	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—SLCO1A2—epilepsy syndrome	8.26e-06	0.000511	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—KCNB1—epilepsy syndrome	8.26e-06	0.000511	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PFKL—epilepsy syndrome	8.26e-06	0.000511	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CYP2D6—epilepsy syndrome	8.01e-06	0.000495	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GLUD1—epilepsy syndrome	7.9e-06	0.000488	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ADK—epilepsy syndrome	7.9e-06	0.000488	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—FAR1—epilepsy syndrome	7.9e-06	0.000488	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—L2HGDH—epilepsy syndrome	7.9e-06	0.000488	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PDXK—epilepsy syndrome	7.9e-06	0.000488	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CERS1—epilepsy syndrome	7.9e-06	0.000488	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—FAR1—epilepsy syndrome	7.88e-06	0.000487	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CERS1—epilepsy syndrome	7.88e-06	0.000487	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ADK—epilepsy syndrome	7.88e-06	0.000487	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—L2HGDH—epilepsy syndrome	7.88e-06	0.000487	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PDXK—epilepsy syndrome	7.88e-06	0.000487	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GLUD1—epilepsy syndrome	7.88e-06	0.000487	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—MMP9—epilepsy syndrome	7.74e-06	0.000479	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ADRA2A—epilepsy syndrome	7.62e-06	0.000471	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—BCHE—epilepsy syndrome	7.59e-06	0.000469	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—UPB1—epilepsy syndrome	7.56e-06	0.000467	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ATIC—epilepsy syndrome	7.56e-06	0.000467	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—NEU1—epilepsy syndrome	7.56e-06	0.000467	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—HSD17B4—epilepsy syndrome	7.27e-06	0.00045	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—SLC2A1—epilepsy syndrome	7.24e-06	0.000448	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GAMT—epilepsy syndrome	7.22e-06	0.000446	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—EPM2A—epilepsy syndrome	7.22e-06	0.000446	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PNPO—epilepsy syndrome	7.22e-06	0.000446	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NHLRC1—epilepsy syndrome	7.22e-06	0.000446	CbGpPWpGaD
Ethosuximide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	7.21e-06	0.000446	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NHLRC1—epilepsy syndrome	7.21e-06	0.000445	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PNPO—epilepsy syndrome	7.21e-06	0.000445	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—EPM2A—epilepsy syndrome	7.21e-06	0.000445	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GAMT—epilepsy syndrome	7.21e-06	0.000445	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PLCB1—epilepsy syndrome	7.16e-06	0.000443	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—SRC—epilepsy syndrome	7.14e-06	0.000441	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—TH—epilepsy syndrome	7.14e-06	0.000441	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	7.07e-06	0.000437	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GBE1—epilepsy syndrome	7.02e-06	0.000434	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PPP1R3C—epilepsy syndrome	7.02e-06	0.000434	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	7.02e-06	0.000434	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	6.97e-06	0.000431	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—VEGFA—epilepsy syndrome	6.95e-06	0.00043	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	6.93e-06	0.000428	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CA4—epilepsy syndrome	6.71e-06	0.000415	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—QDPR—epilepsy syndrome	6.71e-06	0.000415	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CA4—epilepsy syndrome	6.7e-06	0.000414	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—QDPR—epilepsy syndrome	6.7e-06	0.000414	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—POMC—epilepsy syndrome	6.69e-06	0.000414	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—POMC—epilepsy syndrome	6.68e-06	0.000413	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ASAH1—epilepsy syndrome	6.6e-06	0.000408	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—STXBP1—epilepsy syndrome	6.43e-06	0.000397	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	6.34e-06	0.000392	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—COX3—epilepsy syndrome	6.31e-06	0.00039	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—COX3—epilepsy syndrome	6.3e-06	0.000389	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—NT5E—epilepsy syndrome	6.26e-06	0.000387	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ALAD—epilepsy syndrome	6.26e-06	0.000387	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	6.25e-06	0.000386	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PFKL—epilepsy syndrome	5.98e-06	0.00037	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SLCO1A2—epilepsy syndrome	5.98e-06	0.00037	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SLC6A8—epilepsy syndrome	5.98e-06	0.00037	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CACNA2D2—epilepsy syndrome	5.98e-06	0.00037	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—KCNB1—epilepsy syndrome	5.98e-06	0.00037	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ALDH7A1—epilepsy syndrome	5.97e-06	0.000369	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CACNA1A—epilepsy syndrome	5.97e-06	0.000369	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PFKL—epilepsy syndrome	5.97e-06	0.000369	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SLCO1A2—epilepsy syndrome	5.97e-06	0.000369	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SLC6A8—epilepsy syndrome	5.97e-06	0.000369	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—KCNB1—epilepsy syndrome	5.97e-06	0.000369	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CACNA2D2—epilepsy syndrome	5.97e-06	0.000369	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—TNF—epilepsy syndrome	5.96e-06	0.000368	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—HMOX1—epilepsy syndrome	5.96e-06	0.000368	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CAT—epilepsy syndrome	5.88e-06	0.000363	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	5.85e-06	0.000361	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ST3GAL3—epilepsy syndrome	5.85e-06	0.000361	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ADSL—epilepsy syndrome	5.73e-06	0.000354	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ABCB1—epilepsy syndrome	5.72e-06	0.000353	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GLUL—epilepsy syndrome	5.62e-06	0.000347	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CACNA1D—epilepsy syndrome	5.51e-06	0.000341	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—UPB1—epilepsy syndrome	5.47e-06	0.000338	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NEU1—epilepsy syndrome	5.47e-06	0.000338	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ATIC—epilepsy syndrome	5.47e-06	0.000338	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NEU1—epilepsy syndrome	5.46e-06	0.000338	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—UPB1—epilepsy syndrome	5.46e-06	0.000338	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ATIC—epilepsy syndrome	5.46e-06	0.000338	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GPX1—epilepsy syndrome	5.32e-06	0.000329	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—HSD17B4—epilepsy syndrome	5.27e-06	0.000326	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—HSD17B4—epilepsy syndrome	5.26e-06	0.000325	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—TXNRD1—epilepsy syndrome	5.16e-06	0.000319	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GBE1—epilepsy syndrome	5.09e-06	0.000314	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PPP1R3C—epilepsy syndrome	5.09e-06	0.000314	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GBE1—epilepsy syndrome	5.08e-06	0.000314	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PPP1R3C—epilepsy syndrome	5.08e-06	0.000314	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—AQP1—epilepsy syndrome	5.01e-06	0.000309	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CA13—epilepsy syndrome	4.83e-06	0.000299	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ASAH1—epilepsy syndrome	4.78e-06	0.000296	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ASAH1—epilepsy syndrome	4.77e-06	0.000295	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—AGT—epilepsy syndrome	4.66e-06	0.000288	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—STXBP1—epilepsy syndrome	4.65e-06	0.000288	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—STXBP1—epilepsy syndrome	4.64e-06	0.000287	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—APOE—epilepsy syndrome	4.57e-06	0.000282	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ALAD—epilepsy syndrome	4.54e-06	0.00028	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NT5E—epilepsy syndrome	4.54e-06	0.00028	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CHRM3—epilepsy syndrome	4.53e-06	0.00028	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—KCNJ11—epilepsy syndrome	4.53e-06	0.00028	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NT5E—epilepsy syndrome	4.53e-06	0.00028	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ALAD—epilepsy syndrome	4.53e-06	0.00028	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—AKT1—epilepsy syndrome	4.44e-06	0.000274	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CACNA1A—epilepsy syndrome	4.33e-06	0.000267	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ALDH7A1—epilepsy syndrome	4.33e-06	0.000267	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CACNA1A—epilepsy syndrome	4.32e-06	0.000267	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ALDH7A1—epilepsy syndrome	4.32e-06	0.000267	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ST3GAL3—epilepsy syndrome	4.23e-06	0.000262	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ST3GAL3—epilepsy syndrome	4.23e-06	0.000261	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ADSL—epilepsy syndrome	4.15e-06	0.000256	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ADSL—epilepsy syndrome	4.14e-06	0.000256	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GLUL—epilepsy syndrome	4.07e-06	0.000251	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GLUL—epilepsy syndrome	4.06e-06	0.000251	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CACNA1D—epilepsy syndrome	3.99e-06	0.000247	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CACNA1D—epilepsy syndrome	3.98e-06	0.000246	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—POMC—epilepsy syndrome	3.92e-06	0.000242	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—TXNRD1—epilepsy syndrome	3.73e-06	0.000231	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—TXNRD1—epilepsy syndrome	3.73e-06	0.00023	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ABCG2—epilepsy syndrome	3.69e-06	0.000228	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ADK—epilepsy syndrome	3.66e-06	0.000226	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PDXK—epilepsy syndrome	3.66e-06	0.000226	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—FAR1—epilepsy syndrome	3.66e-06	0.000226	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	3.66e-06	0.000226	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	3.66e-06	0.000226	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CERS1—epilepsy syndrome	3.66e-06	0.000226	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—AQP1—epilepsy syndrome	3.63e-06	0.000224	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—AQP1—epilepsy syndrome	3.62e-06	0.000224	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP2C19—epilepsy syndrome	3.6e-06	0.000222	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ALB—epilepsy syndrome	3.58e-06	0.000221	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP11A1—epilepsy syndrome	3.57e-06	0.000221	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GAMT—epilepsy syndrome	3.35e-06	0.000207	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PNPO—epilepsy syndrome	3.35e-06	0.000207	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	3.35e-06	0.000207	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	3.35e-06	0.000207	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—KCNJ11—epilepsy syndrome	3.28e-06	0.000203	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CHRM3—epilepsy syndrome	3.28e-06	0.000203	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—KCNJ11—epilepsy syndrome	3.27e-06	0.000202	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CHRM3—epilepsy syndrome	3.27e-06	0.000202	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP2D6—epilepsy syndrome	3.23e-06	0.000199	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PTGS2—epilepsy syndrome	3.13e-06	0.000193	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—QDPR—epilepsy syndrome	3.12e-06	0.000193	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CA4—epilepsy syndrome	3.12e-06	0.000193	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	3.11e-06	0.000192	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ADRA2A—epilepsy syndrome	3.07e-06	0.00019	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—BCHE—epilepsy syndrome	3.06e-06	0.000189	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—COX3—epilepsy syndrome	2.93e-06	0.000181	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—SLC2A1—epilepsy syndrome	2.92e-06	0.00018	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PLCB1—epilepsy syndrome	2.89e-06	0.000178	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—TH—epilepsy syndrome	2.87e-06	0.000178	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	2.78e-06	0.000172	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	2.78e-06	0.000172	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	2.78e-06	0.000172	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	2.78e-06	0.000172	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PFKL—epilepsy syndrome	2.78e-06	0.000172	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ABCG2—epilepsy syndrome	2.67e-06	0.000165	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	2.67e-06	0.000165	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP2C19—epilepsy syndrome	2.6e-06	0.000161	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	2.6e-06	0.000161	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP11A1—epilepsy syndrome	2.59e-06	0.00016	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	2.58e-06	0.00016	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—UPB1—epilepsy syndrome	2.54e-06	0.000157	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ATIC—epilepsy syndrome	2.54e-06	0.000157	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NEU1—epilepsy syndrome	2.54e-06	0.000157	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	2.44e-06	0.000151	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—HMOX1—epilepsy syndrome	2.4e-06	0.000148	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CAT—epilepsy syndrome	2.37e-06	0.000146	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GBE1—epilepsy syndrome	2.36e-06	0.000146	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	2.36e-06	0.000146	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP2D6—epilepsy syndrome	2.34e-06	0.000144	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	2.33e-06	0.000144	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	2.3e-06	0.000142	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ADRA2A—epilepsy syndrome	2.22e-06	0.000137	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.22e-06	0.000137	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	2.22e-06	0.000137	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—BCHE—epilepsy syndrome	2.21e-06	0.000137	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—BCHE—epilepsy syndrome	2.21e-06	0.000137	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.16e-06	0.000133	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GPX1—epilepsy syndrome	2.14e-06	0.000132	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SLC2A1—epilepsy syndrome	2.11e-06	0.000131	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	2.11e-06	0.00013	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.1e-06	0.00013	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.1e-06	0.00013	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PLCB1—epilepsy syndrome	2.09e-06	0.000129	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	2.09e-06	0.000129	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—TH—epilepsy syndrome	2.08e-06	0.000129	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—TH—epilepsy syndrome	2.08e-06	0.000128	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.01e-06	0.000124	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.01e-06	0.000124	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.96e-06	0.000121	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.92e-06	0.000119	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.89e-06	0.000117	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—AGT—epilepsy syndrome	1.88e-06	0.000116	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.85e-06	0.000114	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—APOE—epilepsy syndrome	1.84e-06	0.000114	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—HMOX1—epilepsy syndrome	1.74e-06	0.000107	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	1.73e-06	0.000107	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.73e-06	0.000107	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CAT—epilepsy syndrome	1.71e-06	0.000106	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CAT—epilepsy syndrome	1.71e-06	0.000106	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.68e-06	0.000104	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ABCB1—epilepsy syndrome	1.67e-06	0.000103	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	1.66e-06	0.000103	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—POMC—epilepsy syndrome	1.58e-06	9.77e-05	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—AKT1—epilepsy syndrome	1.57e-06	9.72e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GPX1—epilepsy syndrome	1.55e-06	9.59e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GPX1—epilepsy syndrome	1.55e-06	9.57e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.52e-06	9.4e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.52e-06	9.4e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ALB—epilepsy syndrome	1.44e-06	8.9e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—AGT—epilepsy syndrome	1.36e-06	8.41e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—AGT—epilepsy syndrome	1.36e-06	8.39e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—APOE—epilepsy syndrome	1.33e-06	8.24e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—APOE—epilepsy syndrome	1.33e-06	8.22e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	1.26e-06	7.79e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.24e-06	7.66e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.21e-06	7.47e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.2e-06	7.42e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—POMC—epilepsy syndrome	1.14e-06	7.07e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—POMC—epilepsy syndrome	1.14e-06	7.06e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.08e-06	6.7e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ALB—epilepsy syndrome	1.04e-06	6.45e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ALB—epilepsy syndrome	1.04e-06	6.44e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.03e-06	6.38e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.03e-06	6.35e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	9.8e-07	6.06e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	9.7e-07	5.99e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—TH—epilepsy syndrome	9.66e-07	5.97e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	9.13e-07	5.64e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	9.11e-07	5.63e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	8.06e-07	4.98e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CAT—epilepsy syndrome	7.96e-07	4.92e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	7.74e-07	4.78e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GPX1—epilepsy syndrome	7.2e-07	4.45e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—AKT1—epilepsy syndrome	6.33e-07	3.92e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—AGT—epilepsy syndrome	6.31e-07	3.9e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—APOE—epilepsy syndrome	6.18e-07	3.82e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—POMC—epilepsy syndrome	5.31e-07	3.28e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ALB—epilepsy syndrome	4.84e-07	2.99e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—AKT1—epilepsy syndrome	4.59e-07	2.84e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—AKT1—epilepsy syndrome	4.58e-07	2.83e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	4.24e-07	2.62e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.13e-07	1.32e-05	CbGpPWpGaD
